chr2-170382053-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138995.5(MYO3B):c.1009G>A(p.Glu337Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000364 in 1,613,536 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138995.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO3B | NM_138995.5 | c.1009G>A | p.Glu337Lys | missense_variant | 10/35 | ENST00000408978.9 | NP_620482.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO3B | ENST00000408978.9 | c.1009G>A | p.Glu337Lys | missense_variant | 10/35 | 1 | NM_138995.5 | ENSP00000386213 | P1 | |
MYO3B-AS1 | ENST00000625968.2 | n.196+1774C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000132 AC: 33AN: 249280Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135246
GnomAD4 exome AF: 0.000387 AC: 565AN: 1461354Hom.: 0 Cov.: 30 AF XY: 0.000345 AC XY: 251AN XY: 726946
GnomAD4 genome AF: 0.000151 AC: 23AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.1009G>A (p.E337K) alteration is located in exon 10 (coding exon 10) of the MYO3B gene. This alteration results from a G to A substitution at nucleotide position 1009, causing the glutamic acid (E) at amino acid position 337 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at